Literature DB >> 6541894

Hypertrophic cardiomyopathy: an important cause of sudden death.

W J McKenna, J E Deanfield.   

Abstract

Retrospective analysis was performed to assess the natural history in relation to clinical and haemodynamic features in 37 patients in whom hypertrophic cardiomyopathy had been diagnosed in childhood. At diagnosis they were aged 1 to 14 years (mean 9 years). Eighteen presented with chest pain and either dyspnoea or symptoms of impaired consciousness or both; 19 were asymptomatic and were referred for evaluation of abnormalities detected during physical examination. During a mean follow up of nine years, 18 patients died, a cumulative annual medical mortality of 4.8%. Five patients experienced severe dyspnoea or chest pain: two of these had progressive dyspnoea and died in cardiac failure, and three died after myectomy. The 19 survivors were compared with the 11 sudden deaths. Eleven of the survivors and five of the sudden deaths were asymptomatic. Of 18 clinical, electrocardiographic, and haemodynamic features only syncope and electrocardiographic evidence of right ventricular hypertrophy were associated with sudden death. In children with hypertrophic cardiomyopathy sudden death was common and was not well predicted by clinical, electrocardiographic, or haemodynamic findings. Hypertrophic cardiomyopathy indicates a poor prognosis even if symptoms are absent or mild.

Entities:  

Mesh:

Year:  1984        PMID: 6541894      PMCID: PMC1628861          DOI: 10.1136/adc.59.10.971

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  17 in total

1.  Asymetric septal hypertrophy in childhood.

Authors:  B J Maron; W L Henry; C E Clark; D R Redwood; W C Roberts; S E Epstein
Journal:  Circulation       Date:  1976-01       Impact factor: 29.690

2.  Familial prevalence and genetic transmission of idiopathic hypertrophic subaortic stenosis.

Authors:  C E Clark; W L Henry; S E Epstein
Journal:  N Engl J Med       Date:  1973-10-04       Impact factor: 91.245

3.  Quantitative analysis of cardiac muscle cell disorganization in the ventricular septum of patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; W C Roberts
Journal:  Circulation       Date:  1979-04       Impact factor: 29.690

4.  M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction.

Authors:  Y L Doi; W J McKenna; J Gehrke; C M Oakley; J F Goodwin
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

5.  An appreciation of hypertrophic cardiomyopathy.

Authors:  J F Goodwin
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965

6.  Prevalence of arrhythmias during 24-hour electrocardiographic monitoring and exercise testing in patients with obstructive and nonobstructive hypertrophic cardiomyopathy.

Authors:  D D Savage; S F Seides; B J Maron; D J Myers; S E Epstein
Journal:  Circulation       Date:  1979-05       Impact factor: 29.690

7.  "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death.

Authors:  B J Maron; L C Lipson; W C Roberts; D D Savage; S E Epstein
Journal:  Am J Cardiol       Date:  1978-06       Impact factor: 2.778

8.  Idiopathic hypertrophic subaortic stenosis in the young.

Authors:  G I Fiddler; A J Tajik; W Weidman; D C McGoon; D G Ritter; E R Giuliani
Journal:  Am J Cardiol       Date:  1978-11       Impact factor: 2.778

9.  Long-term clinical course and symptomatic status of patients after operation for hypertrophic subaortic stenosis.

Authors:  B J Maron; W H Merrill; P A Freier; K M Kent; S E Epstein; A G Morrow
Journal:  Circulation       Date:  1978-06       Impact factor: 29.690

10.  Sudden death in patients with hypertrophic cardiomyopathy: characterization of 26 patients with functional limitation.

Authors:  B J Maron; W C Roberts; J E Edwards; H A McAllister; D D Foley; S E Epstein
Journal:  Am J Cardiol       Date:  1978-05-01       Impact factor: 2.778

View more
  32 in total

Review 1.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 2.  Problems in diagnosis and management of hypertrophic cardiomyopathy.

Authors:  O Odemuyiwa; W J McKenna
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

3.  Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry.

Authors:  Steven E Lipshultz; E John Orav; James D Wilkinson; Jeffrey A Towbin; Jane E Messere; April M Lowe; Lynn A Sleeper; Gerald F Cox; Daphne T Hsu; Charles E Canter; Juanita A Hunter; Steven D Colan
Journal:  Lancet       Date:  2013-09-03       Impact factor: 79.321

4.  Long-term follow-up of children and adolescents diagnosed with hypertrophic cardiomyopathy: risk factors for adverse arrhythmic events.

Authors:  Jeffrey P Moak; Eric S Leifer; Dorothy Tripodi; Saidi A Mohiddin; Lameh Fananapazir
Journal:  Pediatr Cardiol       Date:  2011-04-13       Impact factor: 1.655

5.  Cost-effectiveness of implanted defibrillators in young people with inherited cardiac arrhythmias.

Authors:  Ilan Goldenberg; Arthur J Moss; Barry J Maron; Andrew W Dick; Wojciech Zareba
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

6.  Identification of a mutation in the beta cardiac myosin heavy chain gene in a family with hypertrophic cardiomyopathy.

Authors:  S al-Mahdawi; S Chamberlain; J Cleland; P Nihoyannopoulos; D Gilligan; J French; L Choudhury; R Williamson; C Oakley
Journal:  Br Heart J       Date:  1993-02

7.  Cardiomyopathy of glycogen storage disease type III.

Authors:  J S Carvalho; E E Matthews; J V Leonard; J Deanfield
Journal:  Heart Vessels       Date:  1993       Impact factor: 2.037

8.  Unexpected arrest-related deaths in america: 12 months of open source surveillance.

Authors:  Jeffrey D Ho; William G Heegaard; Donald M Dawes; Sridhar Natarajan; Robert F Reardon; James R Miner
Journal:  West J Emerg Med       Date:  2009-05

Review 9.  Management of arrhythmias in hypertrophic cardiomyopathy.

Authors:  J T Stewart; W J McKenna
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

10.  DDD pacing in hypertrophic cardiomyopathy: a multicentre clinical experience.

Authors:  A K Slade; N Sadoul; L Shapiro; L Chojnowska; J P Simon; R C Saumarez; B Dodinot; A J Camm; W J McKenna; E Aliot
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.